News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Please refer to our letter dated August 8 2022 wherein we have intimated the schedule of Investors/ Analysts call on August 12 2022. We are attaching herewith the Transcript of the analyst / investor call on the Unaudited Financial Results of the Company for the first quarter ended June 30 2022 and the same is being uploaded on the website of the Company and is available in the following web link.https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds